Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11003)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pattison AM, Merlino DJ, Blomain ES, Waldman SA. Guanylyl cyclase C signaling axis and colon cancer prevention. World J Gastroenterol 2016; 22(36): 8070-8077 [PMID: 27688649 DOI: 10.3748/wjg.v22.i36.8070] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i36/8070.htm |
| Number | Citing Articles |
| 1 |
John C Flickinger, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison, Adam E Snook, Scott A Waldman. Guanylyl Cyclase C As A Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies. Biomarkers in Medicine 2021; 15(3): 201 doi: 10.2217/bmm-2020-0359
|
| 2 |
Michela Pucci, Nadia Malagolini, Fabio Dall’Olio. Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases. International Journal of Molecular Sciences 2021; 22(9): 4331 doi: 10.3390/ijms22094331
|
| 3 |
Moein Piroozkhah, Ali Aghajani, Pooya Jalali, Arvin Shahmoradi, Mobin Piroozkhah, Younes Tadlili, Zahra Salehi. Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1277265
|
| 4 |
Houxi Xu, Yuzhu Ma, Jinzhi Zhang, Jialin Gu, Xinyue Jing, Shengfeng Lu, Shuping Fu, Jiege Huo. Identification and Verification of Core Genes in Colorectal Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8082697
|
| 5 |
Jeffrey A. Rappaport, Scott A. Waldman. The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00299
|
| 6 |
Wei-Hui Hu, Gallant Kar-Lun Chan, Ran Duan, Huai-You Wang, Xiang-Peng Kong, Tina Ting-Xia Dong, Karl Wah-Keung Tsim. Synergy of Ginkgetin and Resveratrol in Suppressing VEGF-Induced Angiogenesis: A Therapy in Treating Colorectal Cancer. Cancers 2019; 11(12): 1828 doi: 10.3390/cancers11121828
|
| 7 |
Ke Zhang, Yangbin Xu, Yining Zheng, Ting Zhang, Yujiang Wu, Yiting Yan, Yu Lei, Xi Cao, Xiaolong Wang, Frances Yan, Zhaomin Lei, Daniel Brugger, Yulin Chen, Lu Deng, Yuxin Yang. Bifidobacterium pseudolongum‐Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP‐PKG‐mTORC1 Pathway. Advanced Science 2024; 11(43) doi: 10.1002/advs.202406917
|
| 8 |
Ling Ji, Feizhao Jiang, Xianping Cui, Chengkun Qin. Talin1 knockdown prohibits the proliferation and migration of colorectal cancer cells via the EMT signaling pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.10902
|
| 9 |
Hui Zhang, Yuanyuan Du, Zhuo Wang, Rui Lou, Jianzhong Wu, Jifeng Feng. Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker. Biochemistry Research International 2019; 2019: 1 doi: 10.1155/2019/6469420
|
| 10 |
Samira Nomiri, Reyhane Hoshyar, Elham Chamani, Zohreh Rezaei, Fatemeh Salmani, Pegah Larki, Tahmine Tavakoli, Faranak gholipour, Neda Jalili Tabrizi, Afshin Derakhshani, Mariacarmela Santarpia, Tindara Franchina, Oronzo Brunetti, Nicola Silvestris, Hossein Safarpour. Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study. Biomedicine & Pharmacotherapy 2022; 147: 112691 doi: 10.1016/j.biopha.2022.112691
|
| 11 |
Lichao Cao, Tong Li, Ying Ba, Erfei Chen, Jin Yang, Hezi Zhang. Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.801484
|
| 12 |
Yu Cao, Sergey K. Efetov, Mingze He, Yu Fu, Narasimha M. Beeraka, Jin Zhang, Xinliang Zhang, Namitha Bannimath, Kuo Chen. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae et Therapiae Experimentalis 2023; 71(1) doi: 10.1007/s00005-023-00684-x
|
| 13 |
Ming Li, Ziming Liu, Jia Song, Tian Wang, Hongjie Wang, Yanan Wang, Jiguang Guo. Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.791249
|
| 14 |
Yang Liu, Lanlan Chen, Xiangbo Meng, Shujun Ye, Lianjun Ma. Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.897568
|
| 15 |
Qin Hao, Zhongtao Zhang, Zhihua Kang. hsa_circRNA_000166 Facilitated Cell Growth and Limited Apoptosis through Targeting miR-326/LASP1 Axis in Colorectal Cancer. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8834359
|
| 16 |
Jason C. Huang, Ming-Chun Li, I-Chieh Huang, Je-Ming Hu, Wei-Zhi Lin, Yu-Tien Chang. Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer. Human Gene Therapy 2024; 35(19-20): 855 doi: 10.1089/hum.2023.207
|
| 17 |
Shiquan Li, Guoqiang Yan, Wei Liu, Chenyao Li, Xu Wang. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR‐942‐5p and releasing DLG2 via Hippo‐YAP signaling. Molecular Carcinogenesis 2020; 59(12): 1323 doi: 10.1002/mc.23259
|
| 18 |
Zhen Zhang, Dai Zhang, Yaping Cui, Yongsheng Qiu, Changhong Miao, Xihua Lu. Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5236236
|
| 19 |
Hilde L. von Volkmann, Ingeborg Brønstad, Odd Helge Gilja, Rune R. Tronstad, Dag Andre Sangnes, Ragnar Nortvedt, Trygve Hausken, Georg Dimcevski, Torunn Fiskerstrand, Kim Nylund, Seungil Ro. Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation. PLOS ONE 2017; 12(9): e0185496 doi: 10.1371/journal.pone.0185496
|
| 20 |
Shamik Majumdar, Vishwas Mishra, Somesh Nandi, Mudabir Abdullah, Anaxee Barman, Abinaya Raghavan, Dipankar Nandi, Sandhya S. Visweswariah, Manuela Raffatellu. Absence of Receptor Guanylyl Cyclase C Enhances Ileal Damage and Reduces Cytokine and Antimicrobial Peptide Production during Oral Salmonella enterica Serovar Typhimurium Infection. Infection and Immunity 2018; 86(5) doi: 10.1128/IAI.00799-17
|
| 21 |
Babar Bashir, Dante J. Merlino, Jeffrey A. Rappaport, Esteban Gnass, Juan P. Palazzo, Ying Feng, Eric R. Fearon, Adam E. Snook, Scott A. Waldman. Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia. Human Pathology 2019; 87: 103 doi: 10.1016/j.humpath.2018.11.032
|
| 22 |
Angelika Fretzen. Peptide therapeutics for the treatment of gastrointestinal disorders. Bioorganic & Medicinal Chemistry 2018; 26(10): 2863 doi: 10.1016/j.bmc.2017.11.007
|
| 23 |
Hadi Danaee, Thea Kalebic, Timothy Wyant, Matteo Fassan, Claudia Mescoli, Feng Gao, William L. Trepicchio, Massimo Rugge, Masaru Katoh. Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers. PLOS ONE 2017; 12(12): e0189953 doi: 10.1371/journal.pone.0189953
|
| 24 |
Zhenlong Chen, Rui Ren, Daiwei Wan, Yilin Wang, Xiaofeng Xue, Min Jiang, Jiaqing Shen, Ye Han, Fei Liu, Jianming Shi, Yuting Kuang, Wei Li, Qiaoming Zhi. Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene 2019; 38(32): 6017 doi: 10.1038/s41388-019-0857-8
|
| 25 |
Pooya Jalali, Shahram Aliyari, Marziyeh Etesami, Mahsa Saeedi Niasar, Sahar Taher, Kaveh Kavousi, Ehsan Nazemalhosseini Mojarad, Zahra Salehi. GUCA2A dysregulation as a promising biomarker for accurate diagnosis and prognosis of colorectal cancer. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01512-y
|
| 26 |
Yu-Chen Tang, Yan Zhang, Jin Zhou, Qiaoming Zhi, Meng-Yao Wu, Fei-Ran Gong, Meng Shen, Lu Liu, Min Tao, Bairong Shen, Dong-Mei Gu, Jie Yu, Meng-Dan Xu, Yuan Gao, Wei Li. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4183
|
| 27 |
Jiahao Huang, Fengyun Cong, Yang Zhao, Jinglian Chen, Tao Luo, Weizhong Tang. The circular RNA circ_0001742 regulates colorectal carcinoma proliferation and migration via the MicroRNA-431-5p/ALG8 axis. Heliyon 2024; 10(15): e34660 doi: 10.1016/j.heliyon.2024.e34660
|
| 28 |
Lu-lu Ren, Jia-yi Zhou, Shao-jie Liang, Xiu-qi Wang. Impaired intestinal stem cell activity in ETEC infection: enterotoxins, cyclic nucleotides, and Wnt signaling. Archives of Toxicology 2022; 96(5): 1213 doi: 10.1007/s00204-021-03213-x
|
| 29 |
Olga N. Ilinskaya, Vera V. Ulyanova, Dina R. Yarullina, Ilgiz G. Gataullin. Secretome of Intestinal Bacilli: A Natural Guard against Pathologies. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01666
|
| 30 |
Wendi Shuai, Jiangxue Wu, Shuai Chen, Ranyi Liu, Zhihua Ye, Chunmei Kuang, Xiang Fu, Gaoyuan Wang, Yingchang Li, Qihua Peng, Wei Shi, Yizhuo Li, Qianghua Zhou, Wenlin Huang. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. Cancer Letters 2018; 422: 56 doi: 10.1016/j.canlet.2018.02.023
|
| 31 |
Seyed Taleb Hosseini, Farkhondeh Nemati. Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44459-y
|